HomeComparePCRFF vs JNJ

PCRFF vs JNJ: Dividend Comparison 2026

PCRFF yields 2.10% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCRFF wins by $3.0K in total portfolio value
10 years
PCRFF
PCRFF
● Live price
2.10%
Share price
$15.25
Annual div
$0.32
5Y div CAGR
25%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.3K
Annual income
$3,006.24
Full PCRFF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PCRFF vs JNJ

📍 PCRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCRFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCRFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCRFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRFF
Annual income on $10K today (after 15% tax)
$178.12/yr
After 10yr DRIP, annual income (after tax)
$2,555.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $1,430.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRFF + JNJ for your $10,000?

PCRFF: 50%JNJ: 50%
100% JNJ50/50100% PCRFF
Portfolio after 10yr
$31.8K
Annual income
$3,847.82/yr
Blended yield
12.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCRFF
No analyst data
Altman Z
2.1
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRFF buys
0
JNJ buys
0
No recent congressional trades found for PCRFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCRFFJNJ
Forward yield2.10%2.13%
Annual dividend / share$0.32$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR25%28%
Portfolio after 10y$33.3K$30.3K
Annual income after 10y$3,006.24$4,689.40
Total dividends collected$11.4K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCRFF vs JNJ ($10,000, DRIP)

YearPCRFF PortfolioPCRFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,962$261.93$10,592$272.30+$370.00PCRFF
2$12,065$335.43$11,289$357.73+$776.00PCRFF
3$13,341$431.28$12,123$472.89+$1.2KPCRFF
4$14,831$557.11$13,141$629.86+$1.7KPCRFF
5$16,593$723.57$14,408$846.81+$2.2KPCRFF
6$18,700$945.70$16,021$1,151.60+$2.7KPCRFF
7$21,255$1,245.09$18,122$1,588.22+$3.1KPCRFF
8$24,396$1,653.21$20,930$2,228.20+$3.5KPCRFF
9$28,320$2,216.74$24,792$3,191.91+$3.5KPCRFF
10$33,309$3,006.24$30,274$4,689.40+$3.0KPCRFF

PCRFF vs JNJ: Complete Analysis 2026

PCRFFStock

Panasonic Holdings Corporation, together with its subsidiaries, develops, manufactures, sells, and services various electrical and electronic products worldwide. It operates through Appliances, Life Solutions, Connected Solutions, Automotive, and Industrial Solutions segments. The Appliances segment offers air conditioners, refrigerators, washing machines, vacuum cleaners, microwave ovens, rice cookers, personal care products, TVs, digital cameras, video equipment, home audio equipment, fixed-phones, show cases, compressors, and fuel cells. The Life Solutions segment provides lighting fixtures, lamps, wiring devices, solar photovoltaic systems, spatial sterilizing/deodorizing equipment, interior and exterior furnishing materials, ventilation and air conditioning equipment, air purifiers, bicycles, and nursing care related products, as well as kitchen and bath products. The Connected Solutions segment offers aircraft in-flight entertainment systems and communications services, electronic component mounting machines, welding equipment, PCs and tablets, projectors, and professional AV systems, as well as solutions for various industries. The Automotive segment provides automotive-use infotainment systems, head-up displays, automotive audio systems, automotive switches, vehicle camera modules, advanced driver assistance systems, automotive mirrors, and cylindrical and prismatic lithium-ion batteries, as well as devices and systems for electric automobiles. The Industrial Solutions segment offers relays, switches, power supply products, industrial motors and sensors, capacitors, coils, resistors, electronic circuit board materials, semiconductors, and LCD panels, as well as small lithium–ion, dry, and micro batteries. The company was formerly known as Panasonic Corporation. Panasonic Holdings Corporation was founded in 1918 and is headquartered in Kadoma, Japan.

Full PCRFF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PCRFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRFF vs SCHDPCRFF vs JEPIPCRFF vs OPCRFF vs KOPCRFF vs MAINPCRFF vs ABBVPCRFF vs MRKPCRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.